Do the benefits of finasteride outweigh the risks in the prostate cancer prevention trial?


PURPOSE The Prostate Cancer Prevention Trial demonstrated that finasteride could reduce the incidence of prostate cancer by 25%. However, its use was also associated with an increased risk of high grade cancer resulting in uncertainty surrounding the net benefits of therapy. MATERIALS AND METHODS We used the Montreal Prostate Cancer Model, a validated… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.